Generation of active immunotoxins containing recombinant restrictocin.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1996-05-06

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1996.0697PMID 8630074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB

  2004cited by this paper
• Immunotoxins against cancer.

  1994cited by this paper
• Biologically active interleukin 2-ricin A chain fusion proteins may require intracellular proteolytic cleavage to exhibit a cytotoxic effect.

  1993cited by this paper
• A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies.

  1992cited by this paper
• Recombinant toxins as novel therapeutic agents.

  1992cited by this paper
• Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv)

  1991cited by this paper
• Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome-inactivating protein alpha-sarcin from Aspergillus giganteus.

  1991cited by this paper
• RNA-protein interaction. An analysis with RNA oligonucleotides of the recognition by alpha-sarcin of a ribosomal domain critical for function.

  1990cited by this paper
• Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.

  1989cited by this paper
• The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells.

  1989cited by this paper
• Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.

  1988cited by this paper
• The primary structure of the cytotoxin restrictocin.

  1984cited by this paper
• The site of action of alpha-sarcin on eukaryotic ribosomes. The sequence at the alpha-sarcin cleavage site in 28 S ribosomal ribonucleic acid.

  1982cited by this paper

• A deimmunised form of the ribotoxin, α-sarcin, lacking CD4+ T cell epitopes and its use as an immunotoxin warhead

  2016cites this paper
• Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts

  2015cites this paper
• Immune-O-Toxins as the magic bullet for therapeutic purposes

  2015cites this paper
• Production and characterization of a colon cancer-specific immunotoxin based on the fungal ribotoxin α-sarcin.

  2012cites this paper
• The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

  2012cites this paper
• Implication of an Asp residue in the ribonucleolytic activity of hirsutellin A reveals new electrostatic interactions at the active site of ribotoxins.

  2012cites this paper
• Convergent Potency of Internalized Gelonin Immunotoxins across Varied Cell Lines, Antigens, and Targeting Moieties*

  2010cites this paper
• The therapeutic potential of fungal ribotoxins.

  2008cites this paper
• Involvement of loops L2 and L4 of ribonucleolytic toxin restrictocin in its functional activity.

  2007cites this paper
• Fungal ribotoxins: molecular dissection of a family of natural killers.

  2007cites this paper
• The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells.

  2006cites this paper
• Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.

  2005cites this paper
• Role of cis prolines 112 and 126 in the functional activity of ribonucleolytic toxin restrictocin.

  2002cites this paper
• Mechanism of specific target recognition and RNA hydrolysis by ribonucleolytic toxin restrictocin.

  2001cites this paper
• Assay for antitumor and lectin activity in RNase homologs.

  2001cites this paper
• Localization of the catalytic activity in restrictocin molecule by deletion mutagenesis.

  2000cites this paper
• Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.

  2000cites this paper
• Role of individual cysteine residues and disulfide bonds in the structure and function of Aspergillus ribonucleolytic toxin restrictocin.

  1999cites this paper
• Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.

  1997cites this paper
• Cytotoxic activity of ribonucleolytic toxin restrictocin‐based chimeric toxins targeted to epidermal growth factor receptor

  1997cites this paper
• A single amino acid substitution in ribonucleolytic toxin restrictocin abolishes its specific substrate recognition activity.

  1997cites this paper